Skip to main content
Log in

Association of androgen excess and bone mineral density in women with classical congenital adrenal hyperplasia with 21-hydroxylase deficiency

  • Original Article
  • Published:
Archives of Osteoporosis Aims and scope Submit manuscript

Abstract

Summary

The relationship between androgen excess and bone health in patients with congenital adrenal hyperplasia (CAH) with 21-hydroxylase (21-OH) deficiency is not fully understood. This study demonstrated positive correlations between androgen hormones and bone mineral density (BMD) in CAH women with 21-OH deficiency.

Purpose

This study aims to assess BMD and its association with androgen excess in women with CAH.

Methods

We enrolled 92 women with CAH with 21-OH deficiency and retrospectively reviewed their clinical features, hormone concentrations, body composition, glucocorticoid (GC) dose, and BMD.

Results

BMD was not different according to the subtypes of CAH. BMD at the lumbar spine was lower in women with CAH with regular menstruation than those with irregular menstruation (1.081 vs. 1.165 g/cm2, P < 0.05). BMD was lower in women with CAH with 17-hydroxyprogesterone (17-OHP) < 10 ng/mL than in those with ≥ 10 ng/mL (lumbar spine, 1.019 vs. 1.150 g/cm2; femur neck, 0.806 vs. 0.899 g/cm2; total hip, 0.795 vs. 0.943 g/cm2; all P < 0.05). After adjusting for age and BMI in correlation analyses, testosterone concentrations were positively correlated with lumbar spine, femur neck, and total hip BMD (r = 0.46, r = 0.38, and r = 0.35, respectively; all P < 0.05), while 17-OHP was positively correlated with lumbar spine BMD (r = 0.38, P < 0.01). In subgroup analysis, 17-OHP was positively correlated with BMD (lumbar spine, r = 0.22; femur neck, r = 0.22; total hip, r = 0.24; all P < 0.05) only in the group with a total cumulative dose of GC ≥ 156.0 g/m2.

Conclusion

Androgen excess may have a protective effect on BMD in women with classic CAH and high cumulative doses of GC.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Fig. 1
Fig. 2
Fig. 3

Similar content being viewed by others

References

  1. Speiser PW, Arlt W, Auchus RJ, Baskin LS, Conway GS, Merke DP, Meyer-Bahlburg FHL, Miller WL, Murad MH, Oberfield SE, White PC (2018) Congenital adrenal hyperplasia due to steroid 21-hydroxylase deficiency: an endocrine society clinical practice guideline. J Clin Endocrinol Metab 103:4043–4088. https://doi.org/10.1210/jc.2018-01865

    Article  PubMed  PubMed Central  Google Scholar 

  2. Koetz KR, Ventz M, Diederich S, Quinkler M (2012) Bone mineral density is not significantly reduced in adult patients on low-dose glucocorticoid replacement therapy. J Clin Endocrinol Metab 97:85–92. https://doi.org/10.1210/jc.2011-2036

    Article  CAS  PubMed  Google Scholar 

  3. Riehl G, Reisch N, Roehle R, Claahsen van der Grinten H, Falhammar H, Quinkler M (2020) Bone mineral density and fractures in congenital adrenal hyperplasia: findings from the dsd-LIFE study. Clin Endocrinol (Oxf) 92:284–294. https://doi.org/10.1111/cen.14149

    Article  CAS  PubMed  Google Scholar 

  4. Whittle E, Falhammar H (2019) Glucocorticoid regimens in the treatment of congenital adrenal hyperplasia: a systematic review and meta-analysis. J Endocr Soc 3:1227–1245. https://doi.org/10.1210/js.2019-00136

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  5. Tamhane S, Rodriguez-Gutierrez R, Iqbal AM, Prokop LJ, Bancos I, Speiser PW, Murad MH (2018) Cardiovascular and metabolic outcomes in congenital adrenal hyperplasia: a systematic review and meta-analysis. J Clin Endocrinol Metab 103:4097–4103. https://doi.org/10.1210/jc.2018-01862

    Article  PubMed  Google Scholar 

  6. Lim SG, Lee YA, Jang HN, Kong SH, Ahn CH, Kim SW, Shin CH, Kim JH (2021) Long-term health outcomes of Korean adults with classic congenital adrenal hyperplasia due to 21-hydroxylase deficiency. Front Endocrinol (Lausanne) 12:761258. https://doi.org/10.3389/fendo.2021.761258

    Article  PubMed  Google Scholar 

  7. Lin-Su K, New MI (2007) Effects of adrenal steroids on the bone metabolism of children with congenital adrenal hyperplasia. Ann N Y Acad Sci 1117:345–351. https://doi.org/10.1196/annals.1402.040

    Article  CAS  PubMed  Google Scholar 

  8. Chotiyarnwong P, McCloskey EV (2020) Pathogenesis of glucocorticoid-induced osteoporosis and options for treatment. Nat Rev Endocrinol 16:437–447. https://doi.org/10.1038/s41574-020-0341-0

    Article  PubMed  Google Scholar 

  9. Rangaswamaiah S, Gangathimmaiah V, Nordenstrom A, Falhammar H (2020) Bone mineral density in adults with congenital adrenal hyperplasia: a systematic review and meta-analysis. Front Endocrinol (Lausanne) 11:493. https://doi.org/10.3389/fendo.2020.00493

    Article  PubMed  Google Scholar 

  10. Falhammar H, Filipsson H, Holmdahl G, Janson PO, Nordenskjold A, Hagenfeldt K, Thoren M (2007) Fractures and bone mineral density in adult women with 21-hydroxylase deficiency. J Clin Endocrinol Metab 92:4643–4649. https://doi.org/10.1210/jc.2007-0744

    Article  CAS  PubMed  Google Scholar 

  11. Hagenfeldt K, Martin Ritzen E, Ringertz H, Helleday J, Carlstrom K (2000) Bone mass and body composition of adult women with congenital virilizing 21-hydroxylase deficiency after glucocorticoid treatment since infancy. Eur J Endocrinol 143:667–671. https://doi.org/10.1530/eje.0.1430667

    Article  CAS  PubMed  Google Scholar 

  12. Falhammar H, Frisen L, Hirschberg AL, Nordenskjold A, Almqvist C, Nordenstrom A (2021) Increased prevalence of fractures in congenital adrenal hyperplasia: a Swedish population-based national cohort study. J Clin Endocrinol Metab. https://doi.org/10.1210/clinem/dgab712

    Article  PubMed  PubMed Central  Google Scholar 

  13. Bachelot A, Chakhtoura Z, Plu-Bureau G, Coudert M, Coussieu C, Badachi Y, Dulon J, Charbit B, Touraine P (2012) Influence of hormonal control on LH pulsatility and secretion in women with classical congenital adrenal hyperplasia. Eur J Endocrinol 167:499–505. https://doi.org/10.1530/EJE-12-0454

    Article  CAS  PubMed  Google Scholar 

  14. White PC, Speiser PW (2000) Congenital adrenal hyperplasia due to 21-hydroxylase deficiency. Endocr Rev 21:245–291. https://doi.org/10.1210/edrv.21.3.0398

    Article  CAS  PubMed  Google Scholar 

  15. Lin-Su K, Harbison MD, Lekarev O, Vogiatzi MG, New MI (2011) Final adult height in children with congenital adrenal hyperplasia treated with growth hormone. J Clin Endocrinol Metab 96:1710–1717. https://doi.org/10.1210/jc.2010-2699

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  16. Liu XS, Cohen A, Shane E, Yin PT, Stein EM, Rogers H, Kokulus SL, McMahon DJ, Lappe JM, Recker RR, Lang T, Guo XE (2010) Bone density, geometry, microstructure, and stiffness: relationships between peripheral and central skeletal sites assessed by DXA, HR-pQCT, and cQCT in premenopausal women. J Bone Miner Res 25:2229–2238. https://doi.org/10.1002/jbmr.111

    Article  PubMed  PubMed Central  Google Scholar 

  17. El-Maouche D, Collier S, Prasad M, Reynolds JC, Merke DP (2015) Cortical bone mineral density in patients with congenital adrenal hyperplasia due to 21-hydroxylase deficiency. Clin Endocrinol (Oxf) 82:330–337. https://doi.org/10.1111/cen.12507

    Article  CAS  PubMed  Google Scholar 

  18. Carmina E, Guastella E, Longo RA, Rini GB, Lobo RA (2009) Correlates of increased lean muscle mass in women with polycystic ovary syndrome. Eur J Endocrinol 161:583–589. https://doi.org/10.1530/EJE-09-0398

    Article  CAS  PubMed  Google Scholar 

  19. Escobar-Morreale HF, Alvarez-Blasco F, Botella-Carretero JI, Luque-Ramirez M (2014) The striking similarities in the metabolic associations of female androgen excess and male androgen deficiency. Hum Reprod 29:2083–2091. https://doi.org/10.1093/humrep/deu198

    Article  CAS  PubMed  Google Scholar 

  20. Kim J, Kwon H, Heo BK, Joh HK, Lee CM, Hwang SS, Park D, Park JH (2018) The association between fat mass, lean mass and bone mineral density in premenopausal women in Korea: a cross-sectional study. Korean J Fam Med 39:74–84. https://doi.org/10.4082/kjfm.2018.39.2.74

    Article  PubMed  PubMed Central  Google Scholar 

  21. Wang MC, Bachrach LK, Van Loan M, Hudes M, Flegal KM, Crawford PB (2005) The relative contributions of lean tissue mass and fat mass to bone density in young women. Bone 37:474–481. https://doi.org/10.1016/j.bone.2005.04.038

    Article  CAS  PubMed  Google Scholar 

  22. Chakhtoura Z, Bachelot A, Samara-Boustani D et al (2008) Impact of total cumulative glucocorticoid dose on bone mineral density in patients with 21-hydroxylase deficiency. Eur J Endocrinol 158:879–887. https://doi.org/10.1530/EJE-07-0887

    Article  CAS  PubMed  Google Scholar 

  23. Falhammar H, Filipsson Nystrom H, Wedell A, Brismar K, Thoren M (2013) Bone mineral density, bone markers, and fractures in adult males with congenital adrenal hyperplasia. Eur J Endocrinol 168:331–341. https://doi.org/10.1530/EJE-12-0865

    Article  CAS  PubMed  Google Scholar 

  24. Lindberg MK, Vandenput L, Moverare Skrtic S, Vanderschueren D, Boonen S, Bouillon R, Ohlsson C (2005) Androgens and the skeleton. Minerva Endocrinol 30:15–25

    CAS  PubMed  Google Scholar 

  25. King JA, Wisniewski AB, Bankowski BJ, Carson KA, Zacur HA, Migeon CJ (2006) Long-term corticosteroid replacement and bone mineral density in adult women with classical congenital adrenal hyperplasia. J Clin Endocrinol Metab 91:865–869. https://doi.org/10.1210/jc.2005-0745

    Article  CAS  PubMed  Google Scholar 

Download references

Acknowledgements

We are grateful to Sei Won Yang, the emeritus professor of pediatrics at Seoul National University College of Medicine, and Seong Yeon Kim, the emeritus professor of internal medicine at Seoul National University College of Medicine.

Funding

This study was funded by a donation from one CAH patient.

Author information

Authors and Affiliations

Authors

Contributions

DHL, SHK, and JHK conceived and designed the analysis. DHL, SHK, HNJ, SGL, YAL, and JHK collected the data. All authors contributed to data analysis and interpretation. DHL and JHK drafted the manuscript, and all authors provided critical revisions. All authors gave final approval of the version of the manuscript submitted for publication.

Corresponding author

Correspondence to Jung Hee Kim.

Ethics declarations

Ethics approval

This study was performed in accordance with the principles of the Declaration of Helsinki. The Seoul National University Hospital Institutional Review Board (H-2004–147-1118) approved this study.

Consent to participate

This study waived the requirement for informed consent.

Conflict of interest

The authors declare no competing interests.

Additional information

Publisher's note

Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Lee, D.H., Kong, S.H., Jang, H.N. et al. Association of androgen excess and bone mineral density in women with classical congenital adrenal hyperplasia with 21-hydroxylase deficiency. Arch Osteoporos 17, 45 (2022). https://doi.org/10.1007/s11657-022-01090-0

Download citation

  • Received:

  • Accepted:

  • Published:

  • DOI: https://doi.org/10.1007/s11657-022-01090-0

Keywords

Navigation